Axel Bex

10PUBLICATIONS
62CO-AUTHORS
Epidemiological methodsMedical genetics (excl. cancer genetics)Solid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Implementation science and evaluation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 11, 2026
Surgical waiting times in patients with high- and low-risk renal cell carcinoma in England.

|Oct 01, 2026
Towards sustainable multidisciplinary renal cancer tumour boards: redesigning the referral pathway.

|Jun 11, 2026
Modern management of locally advanced renal cancers with inferior vena cava thrombus.

|Sep 20, 2024
Adjuvant Nivolumab for Localized Renal Cell Carcinoma at High Risk of Recurrence After Nephrectomy: Part B of the Randomized, Placebo-Controlled, Phase III CheckMate 914 Trial.

Robert J Motzer, Axel Bex, Paul Russo

|Jul 22, 2022
Cost-Utility Analysis of Major System Change in Specialist Cancer Surgery in London, England, Using Linked Patient-Level Electronic Health Records and Difference-in-Differences Analysis.

Caroline S Clarke, Mariya Melnychuk, Angus I G Ramsay

|May 03, 2022
Surgical margins after partial nephrectomy as prognostic factor for the risk of local recurrence in pT1 RCC: a systematic review and narrative synthesis.

Michaël M E L Henderickx, Suraj V Baldew, Lorenzo Marconi

Pageof 2

Frequent Collaborators

3 joint publications

Grant D Stewart

3 joint publications

Maxine Tran

2 joint publications

Bhavna Oza

2 joint publications

Tim Eisen